NCT06339567View on ClinicalTrials.gov

Evaluation of the Venous Thrombotic Biological Profile of Different PCOS Phenotypes: French Cross-sectional Study

NAActive, not recruitingINTERVENTIONAL

Enrollment

352

Participants

Timeline

Start Date

February 8, 2024

Primary Completion Date

February 7, 2026

Study Completion Date

February 7, 2029

Conditions

Polycystic Ovary Syndrome

Interventions

DIAGNOSTIC_TEST

Thrombotic profile

several thrombotic biological marker will be dosed in blood. (C protein, S protein, CRP us, Factor VIII, TFPI , nAPCsr, SHBG, nTMsr)

Trial Locations (1)

Unknown

Hôpital Paris Saint Joseph, Paris

All Listed Sponsors

lead

Fondation Hôpital Saint-Joseph

OTHER

NCT06339567 - Evaluation of the Venous Thrombotic Biological Profile of Different PCOS Phenotypes: French Cross-sectional Study | Biotech Hunter | Biotech Hunter